References
- Mårtensson B., Åberg-Wistedt A. Selektiva hammare av serotoninupptag. Ny grupp av antide-pressiva medel ökar i användning. Lakartidningen 1994; 91: 3371–9
- Boyer W. Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis. Int Clin Psychopharmacol 1995; 10: 45–9
- Oehrberg S., Christiansen P. E., Behnke K., Borup A. L., Soegaard J., Calberg H. Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebocontrolled study. Br J Psychiatry 1995; 167: 374–9
- Stein D. J., Spadaccini E., Hollander E. Meta-analysis of pharmacotherapy trials for obsessive-compulsive disorder. Int Clin Psychopharmacol 1995; 10: 11–8
- Greist J. H., Jefferson J. W., Kobak K. A., Chouinard G., Duboff E., Halaris A. A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder. Int Clin Psychopharmacol 1995; 10: 57–65
- Danish University Antidepressant Group. Citalo-pram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Psy-chopharmacology 1986; 90: 131–8
- Danish University Antidepressant Group. Paroxetine: a selective reuptake inhibitor showing better tolerance but weaker antidepressant effect than clomipramine in a controlled multicenter study. J Affect Disord 1990; 18: 289–99
- Roose S. P., Glassman A. H., Attia E., Woodring S. Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiatry 1994; 151: 1735–9
- Tignol J. Treatment of severe depression with paroxetine. Eur Psychiatry 1993; 8 Suppl l: 21s–3s
- Nierenberg A. A. The treatment of severe depression: is there an efficacy gap between SSRI and TCA antidepressant generations?. J Clin Psychiatry 1994; 55 Suppl A: 55–9
- Montgomery S. A., Pedersen V., Tanghøj P., Rasmus-Sen C, Rioux P. The optimal dosing regimen for citalopram-a meta-analysis of nine placebo-controlled studies. Int Clin Psychopharmacol 1994; 9 Suppl 1: 35–40
- Clerc G. E., Ruimy P., Verdeau-Paillés J., Venlafaxine French Inpatient Study Group. A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. Int Clin Psychopharmacol 1994; 9: 139–43
- Katona CLE, Abouh-Saleh M. T., Harrison D. A., Nairac B. A., Edwards DRL, Lock T. Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine. Br J Psychiatry 1995; 166: 80–6
- Medhus A., Heskestad S., Tjemsland L. Mianserin added to tricyclic antidepressants in depressed patients not responding to a tricyclic antidepressant alone. Nord J Psychiatry 1994; 48: 355–8
- Joffe R. T., Schuller D. R. An open study of buspirone augmentation of serotonin reuptake inhibitors in refractory depression. J Clin Psychiatry 1993; 54: 269–71
- Artigas F., Perez V., Alvarez E. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch Gen Psychiatry 1994; 51: 248–51
- Fava G. A., Grandi S. Withdrawal syndromes after paroxetine and sertraline discontinuation. J Clin Psychopharmacol 1995; 15: 374–5
- Sternbach H. The serotonin syndrome. Am J Psychiatry 1991; 157: 705–13
- Beaumont G. Sexual side-effects of clomipramine (Anafranil). J Int Med Res 1973; 1: 469–72
- Salzman. Dealing with the sexual side effects of SSRI antidepressants. J Prac Psych Behav Health 1995; 37–9
- Stein D. J., Hollander E. Sexual dysfunction associated with the drug treatment of psychiatric disorders. Incidence and treatment. CNS Drugs 1994; 2: 78–86
- Wålinder J. Comparative efficacy and safety of selective serotonin reuptake inhibitors in the short-and medium-term treatment of major depressive disorders. Nord J Psychiatry 1996; 50: 55–9
- Aguglia E., Casacchia M., Cassano G. B., Faravelli C., Ferrari G., Giordano P. Double blind study of the efficacy and safety of sertraline versus fluoxetine in major depression. Int Clin Psychopharmacol 1993; 8: 197–202
- Ansseau M., Gabriels A., Loyens J., Bartholome F., Evrard J. L., de Nayer A. Controlled comparison of paroxetine and fluvoxamine in major depression. Human Psychopharmacol 1994; 9: 329–36
- Brown W. A., Harrison W. Are patients who are intolerant to one serotonin selective reuptake intolerant to another. J Clin Psychiatry 1995; 56: 30–4
- Nemeroff C. B., de Vane C. L., Pollock B. G. Newer antidepressants and the cytochrome P450 system. Am J Psychiatry 1996; 153: 311–20
- Kramer P. D. Listening to Prozac. Penguin Books, New York 1994